Coexpression of PDGFR-alpha, PDGFR-beta and VEGF as a prognostic factor in patients with hepatocellular carcinoma.
about
Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survivalPDGFRα in liver pathophysiology: emerging roles in development, regeneration, fibrosis, and cancerIdentification of five serum protein markers for detection of ovarian cancer by antibody arraysActionable gene expression-based patient stratification for molecular targeted therapy in hepatocellular carcinomaImmunohistochemical expression of platelet-derived growth factor receptors in ovarian cancer patients with long-term follow-up.Dovitinib preferentially targets endothelial cells rather than cancer cells for the inhibition of hepatocellular carcinoma growth and metastasis.Expression and prognostic value of VEGFR-2, PDGFR-β, and c-Met in advanced hepatocellular carcinoma.Decorin interferes with platelet-derived growth factor receptor signaling in experimental hepatocarcinogenesis.Prognostic significance of vascular endothelial growth factor expression in hepatocellular carcinoma tissue: a meta-analysisTargeting platelet-derived growth factor (PDGF) signaling in gastrointestinal cancers: preclinical and clinical considerations.Over-expression of VEGF and MMP-9 in residual tumor cells of hepatocellular carcinoma after embolization with lipidol.Clinical significance of platelet-derived growth factor receptor-β gene expression in stage II/III gastric cancer with S-1 adjuvant chemotherapy.Pretreatment MicroRNA Level and Outcome in Sorafenib-treated Hepatocellular Carcinoma.Overexpression of c-kit(CD117), relevant with microvessel density, is an independent survival prognostic factor for patients with HBV-related hepatocellular carcinoma.
P2860
Q26853543-6B79B342-C669-421C-B4D3-6710DA8AFDBFQ28085644-BD19AE71-D78F-4A7A-924D-A384EBFD08D4Q28534203-8E8E3673-77B6-454D-8A17-212348ABB2D2Q31119684-6878E56E-1C09-44A1-A231-E6485526EE6EQ36289382-E79886C3-2A4C-4F46-A9C7-EFBA50CF01F0Q36555872-46B235B5-51F8-45E7-AD60-FA9D4B15E676Q36758735-CD4874C3-8134-44A2-9FA9-ABDC978C8388Q36836945-2D509A1F-D996-43D7-90B8-ABF853ED235AQ37584674-0FF99183-E706-4D97-8EB5-F8AF8B4432BBQ38268000-8FD206E5-56BD-41BD-8037-55B7A79E10DBQ39197756-FEEA9383-29EF-402E-907F-8DEABB636F85Q41966545-C7A57550-5280-4734-9B5E-037B1C155B5DQ46124376-AFB689DD-B857-4D14-95EE-D0985407B85AQ54251361-567810D5-415C-40E1-89B7-987D2A7E6CEE
P2860
Coexpression of PDGFR-alpha, PDGFR-beta and VEGF as a prognostic factor in patients with hepatocellular carcinoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Coexpression of PDGFR-alpha, P ...... with hepatocellular carcinoma.
@en
Coexpression of PDGFR-alpha, P ...... with hepatocellular carcinoma.
@nl
type
label
Coexpression of PDGFR-alpha, P ...... with hepatocellular carcinoma.
@en
Coexpression of PDGFR-alpha, P ...... with hepatocellular carcinoma.
@nl
prefLabel
Coexpression of PDGFR-alpha, P ...... with hepatocellular carcinoma.
@en
Coexpression of PDGFR-alpha, P ...... with hepatocellular carcinoma.
@nl
P2093
P356
P1476
Coexpression of PDGFR-alpha, P ...... with hepatocellular carcinoma
@en
P2093
Cheng-Ying Jiang
Guang-Hai Dai
Li-Xin Wei
Yu-Lan Wang
P304
P356
10.5301/JBM.2011.8322
P50
P577
2011-04-01T00:00:00Z